Literature DB >> 4943925

Cellular and humoral immunity against human malignant melanoma.

G Fossati, M I Colnaghi, G D Porta, N Cascinelli, U Veronesi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4943925     DOI: 10.1002/ijc.2910080221

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  15 in total

Review 1.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

Review 2.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

3.  [Influence of autologous serum on leucocyte-migration-inhibition-test in melanomalignoma (author's transl)].

Authors:  J Fritz; K Grond
Journal:  Arch Dermatol Res       Date:  1977-04-27       Impact factor: 3.017

4.  Cellular immunity to breast carcinoma and malignant melanoma.

Authors:  A J Cochran; R M Mackie; C E Thomas; R M Grant; D E Cameron-Mowat; W G Spilg
Journal:  Br J Cancer Suppl       Date:  1973-08

5.  Immune responses to tumour and embryo cells in patients with mammary carcinoma.

Authors:  G Della Porta; S Canevari; G Fossati
Journal:  Br J Cancer Suppl       Date:  1973-08

Review 6.  Natural killer cells: artifact to reality: an odyssey in biology.

Authors:  R K Oldham
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

7.  [Mitogenic activity of melanoma extracts in leucocyte cultures (author's transl)].

Authors:  G Lischka
Journal:  Arch Dermatol Res       Date:  1975-09-12       Impact factor: 3.017

8.  [Immunfluorescence of human brain tumours (author's transl)].

Authors:  D K Böker
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

9.  [Cellular immunity in melanomalignome (author's transl)].

Authors:  J Fritz; K Grond; G P Tilz
Journal:  Arch Dermatol Res       Date:  1976-04-21       Impact factor: 3.017

10.  Tuberculin and dinitrochlorobenzene (DNCB) tests in cancer patients before and after cytostatic drug therapy.

Authors:  W Weber; H P Missmahl; B Mazloumi
Journal:  Klin Wochenschr       Date:  1978-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.